• Featured Product
  • KD/KO Validated

PLOD2 Monoklonaler Antikörper

PLOD2 Monoklonal Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Maus / IgA

Getestete Reaktivität

human

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1H9E1

Kat-Nr. : 66342-1-PBS

Synonyme

1H9E1, EC:1.14.11.4, Lysyl hydroxylase 2, PLOD2/LH2, Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2



Geprüfte Anwendungen

Produktinformation

66342-1-PBS bindet in WB, IHC, Indirect ELISA PLOD2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgA
Klonalität Monoklonal
Typ Antikörper
Immunogen PLOD2 fusion protein Ag5779
Vollständiger Name procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
Berechnetes Molekulargewicht 758 aa, 85 kDa
Beobachtetes Molekulargewicht 87 kDa
GenBank-ZugangsnummerBC037169
Gene symbol PLOD2
Gene ID (NCBI) 5352
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

PLOD2,also named as LH2, forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. It is a potential novel prognostic factor for HCC patients following surgery. Among the PLOD genes, PLOD2 contributes to cancer prognosis and angiogenesis. Several authors have reported that PLOD2 expression might provide prognostic information about malignant tumours such as glioblastoma. PLOD2 expression is a useful biomarker for the effects of antiangiogenic treatment for malignancy.(PMID:22098155). It has 2 isoforms produced by alternative splicing and seven glycosylation sites.